The Congressional Research Service indicates it "could be likely" that the US Drug Enforcement Administration will reschedule marijuana. In October last year, President Joe Biden announced a review of how marijuana is scheduled under federal law involving the Department of Health and Human Services (HHS) and the Attorney General....

Nebraskans for Medical Marijuana (NMM) has formally kicked off its signature collection drive to put the legalization of medical cannabis before Nebraskan voters in November 2024. This is the third time NMM has attempted to get the issue on the ballot. While its campaign collected more than enough signatures in...

In the USA, more than a dozen Republican lawmakers have put their name to a letter urging the Drug Enforcement Administration to maintain marijuana's Schedule I status. Schedule I status is reserved for substances with a high potential for abuse, no currently accepted medical use, and a lack of accepted...

A recent meeting of Pennsylvania's Medical Marijuana Board gave a green light for podiatrist prescribers, but its red light will remain for edibles. One of the items on the Board's September 6 meeting was discussion and consideration of a recommendation to add podiatrists to the list of practitioners who can...

A major Australian multicenter study has indicated medicinal cannabis is providing health related quality of life (HRQL) and other benefits for patients. The Australian Government backed QUEST* Initiative involved 2762 participants who had been prescribed medicinal cannabis between November 2020 and December 2021 across six Australian states. As well...

Another study has revealed cannabis use is prevalent among cancer patients in the USA - but often their oncologists don't know. In this latest study, patients with various types of cancers residing in states where medical cannabis is legal and who were being treated at Memorial Sloan Kettering Cancer Center...

Australian medical cannabis company Bod Science Limited (ASX:BOD) has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD (cannabidiol) product for the local market. In late 2020, Australia's Therapeutic Goods Administration (TGA) announced it would down-schedule certain cannabidiol (CBD) preparations to Schedule 3...

Medical cannabis company Cannatrek has been successful in securing Good Manufacturing Practice (GMP) accreditation for its Shepparton facility in regional Victoria. The $5 million manufacturing facility, which has received support from the Victorian Government, is part of a planned $17 million investment by Cannatrek into the region that incorporates cultivation...

Those wanting to attend the 2023 Global Hemp Manufacturing and Commercialisation Summit being held in Melbourne, Australia late this month only have a couple of days left to register. Hosted by the University of Melbourne, this year's event will be held Wednesday 27th - Thursday 28th of September at Graduate...

A Health Canada study has indicated a huge difference in pesticide prevalence between regulated and illicit cannabis. Medicinal cannabis has been legal in Canada since 2001 and was legalised for recreational use in 2018. Among the requirements for licensed producers is no unauthorized pesticides are used to treat cannabis or...